tiprankstipranks
Trending News
More News >

Acotec Scientific Gains Approval for Innovative Catheter in China

Story Highlights
Acotec Scientific Gains Approval for Innovative Catheter in China

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from Acotec Scientific Holdings Limited ( (HK:6669) ).

Acotec Scientific Holdings Limited announced that it has received approval from the PRC National Medical Products Administration for its Vertebral Artery Paclitaxel-coated Balloon Dilatation Catheter, AcoArt Verbena®. This product is designed for percutaneous transluminal angioplasty in patients with significant vertebral artery stenosis. Clinical trials have shown its efficacy and safety, with a notable reduction in restenosis rates compared to control groups. This approval marks a significant advancement in the treatment of vertebral artery stenosis, potentially reducing the risk of stroke. The company plans to initiate marketing activities in the PRC market, although successful commercialization is not guaranteed.

More about Acotec Scientific Holdings Limited

Acotec Scientific Holdings Limited is a company incorporated in the Cayman Islands, focusing on the development of medical devices. The company operates within the healthcare industry, providing innovative solutions for medical treatments.

Average Trading Volume: 302,227

Technical Sentiment Signal: Buy

Current Market Cap: HK$2.44B

See more data about 6669 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1